The CD4
+
CD25
+
Regulatory T Cell Isolation Kit has been used to investigate the role of CD4
+
CD25
+
regulatory T cells in autoimmune diseases
1,2
, antitumor immunity
3–6
, allergy
7
, and in infectious diseases
8
. For further characterization, CD4
+
CD25
+
regulatory T cells were isolated from patients suffering from rheumatoid arthritis
1
or multiple sclerosis
2
, from acute T cell lymphoma patients
4
, from tumor biopsy specimens of non-Hodgkin lymphoma patients
5
, after dendritic cell vaccination
9
as well as from patients with atopic dermatitis
7
.